ACHIEVING BUSINESS AND LEGAL GOALS DURING UNCERTAIN TIMES

This virtual program, streaming live May 10 through May 12, will examine the legal, regulatory, and business landscape facing health care and life sciences companies during one of the world's most unsettled, yet opportunistic, times. To learn more about the Summit faculty and program details, click here. The Summit brings together leading lawyers, consultants, government workers, private equity investors, and government and business leaders including:

DR. KURT NEWMAN 

PRESIDENT & CEO

NATIONAL CHILDREN'S HOSPITAL

MARK ABDOO 

ASSOCIATE COMMISSIONER FOR GLOBAL POLICY AND STRATEGY

U.S. FOOD AND DRUG ADMINISTRATION

DR. BARBARA LEE BASS 

DEAN

GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

DIVYA MEHTA

SENIOR VP & GENERAL COUNSEL

KONE AMERICAS LEGAL

BENJAMIN STUTZ 

CHIEF OPERATING OFFICER

DEPARTMENT OF HEALTH CARE FINANCE

DIRECTOR

CEDAR HILL REGIONAL MEDICAL CENTER – GW HEALTH

FOR THE DEPUTY MAYOR FOR HEALTH & HUMAN SERVICES

KIM RUSSO 

CEO

THE GEORGE WASHINGTON UNIVERSITY HOSPITAL

GROUP VP

WASHINGTON, D.C. REGION OF UNIVERSAL HEALTH SERVICES

PAMELA SIMPKINS 

SR. DIRECTOR & STRATEGY LEAD, OFFICE OF CHIEF MEDICAL OFFICER

JOHNSON & JOHNSON

SEAN O'GRADY 

PRESIDENT

NORTH REGION & INSTITUTES

NORTHSHORE – EDWARD-ELMHURST HEALTH

WENDY CHOW

GENERAL COUNSEL

CITYBLOCK HEALTH

STEPHANIE NORIEA 

GENERAL COUNSEL, SVP OF BUSINESS DEVELOPMENT, SVP OF GOVERNMENT AFFAIRS

READY RESPONDERS

LESLIE HESS 

GENERAL COUNSEL & CHIEF COMPLIANCE/RISK OFFICER

DELTA DENTAL OF ARIZONA

VIRGINIA MACSUIBHNE 

CHIEF COMPLIANCE & PRIVACY OFFICER

AGILENT

SUBBU RAMANARAYANAN 

MANAGING DIRECTOR

NERA ECONOMIC CONSULTING

MORTEN BULL

EXECUTIVE DIRECTOR

LEO PHARMA 

JASON GARBELL

SENIOR DIRECTOR

NOVOZYMES 

NIELS FISCHER 

HEAD OF M&A AND STRATEGY

OTERRA  

BRAD LURIA

GENERAL COUNSEL,

NORTH AMERICA

LONZA BIOLOGICS

View all speakers here.

The three-day program includes sessions in three main areas of focus:

  1. Disputes in the health care and life sciences sector involving global vaccine mandates, COVID-19, and antitrust enforcement in the Biden administration;
  2. Regulatory and policy trends, including public-private partnerships in health care, FDA policy and business priorities in pharma and devices, and medtech regulatory considerations; and
  3. Challenges and opportunities for U.S.-based health care companies in the M&A space, what to know about security breach preparedness, and employment benefits and executive compensation issues in the health care & life sciences industry.

TUESDAY, MAY 10

10 a.m. – 2 p.m. ET 

WEDNESDAY, MAY 11

10 a.m. – 3 p.m. ET

THURSDAY, MAY 12

11 a.m. – 3 p.m. ET 

Note: Following live streaming, programs will be made available for on-demand viewing to registered attendees in order to accommodate audiences in different time zones.

REGISTER

Access credentials provided upon registration.